Development of macro/micro porous silk fibroin scaffolds with nano-sized calcium phosphate particles for bone tissue engineering — Leping Yan (2012) | RDL Network
Development of macro/micro porous silk fibroin scaffolds with nano-sized calcium phosphate particles for bone tissue engineering
Article 2012 en
Authors
LY
Leping Yan
CC
Cristina Correia
JS
Joana Silva‐Correia
Abstract
1 min read
Macro/micro porous silk scaffolds with nano-sized calcium phosphate (CaP) particles were developed for bone tissue engineering. Different amounts of nano-sized CaP particles 4, 8, 16 and 25% (CaP:silk fibroin, wt/wt) were generated into the highly concentrated aqueous silk fibroin solutions via an in-situ approach. Afterwards, the pure silk and silk/nano-CaP porous scaffolds were produced by a combination of salt-leaching/freeze-drying methods. Thermal gravimetric analysis results were able to demonstrated that the silk/nano-CaP scaffolds maintained 64–87% of incorporated CaP after salt-leaching. Dynamic mechanical analysis showed that storage modulus of the 16% formulation was significantly higher than all remaining groups. The porosity of silk/nano-CaP scaffolds assessed using Micro-Computed Tomography decreased from 79.8% to 63.6% with increasing CaP incorporated until 16%. By soaking the scaffolds in Simulated Body Fluid for 7 days, cauliflower-like apatite clusters were observed on the surface of both macro and micro pores of 16% and 25% formulations, which was not observed in 4 and 8% formulations. 16% silk/nano-CaP scaffolds were further chosen for in vitro cytotoxicity and biocompatibility assays. Both silk and 16% silk/nano-CaP scaffolds were non-cytotoxic and promoted cell adhesion and proliferation to a similar extent. These results indicated that the 16% silk/ nano-CaP scaffolds could be a good candidate for bone tissue engineering.
Leping Yan, Joana Silva‐Correia, Cristina Correia, Sofia G. Caridade, Emanuel M. Fernandes, Rui A. Sousa, João F. Mano, Joaquím M. Oliveira, Ana L. Oliveira, Rui L Reis
Discussion(0)
No comments yet. Be the first to comment.